About Rivarp Medical
Rivarp Medical is a Healthcare company based in Bengaluru (India) founded in 2016. It manufactures medical devices for cardiology and spinal procedures globally. It operates on a B2B model. The company has 46 employees. Its Indian entity Rivarp Medical Private Limited reported revenue of ₹19.12 Cr. Rivarp Medical offers products and services including Occlunix® Occluders, PTCA Balloon Catheters, and Kentrospine Implants. Its focus areas include Medical Devices, Cardiology, Interventional Devices and Orthopedics.
Company details
Rivarp Medical Pvt. Ltd. focuses on designing and producing advanced medical devices, including occluders and catheters for cardiology interventions, as well as implants for spine surgeries. The company operates from Bangalore, India, emphasizing innovative healthcare solutions through manufacturing and distribution. Their products support medical professionals in treating heart defects and spinal conditions, serving hospitals and clinics worldwide.
- Headquarters Bengaluru, India
- Employees 46
- SectorsHealthcare
- Email••••••••
- Website rivarpmedical.com
- Social LinkedIn Facebook YouTube
- Legal Name Rivarp Medical Private Limited
- Date of Incorporation 07 Jul, 2015
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹19.12 Cr
FY 2024 · +32% YoY
- Net Profit₹1.75 Cr
FY 2024 · 9% margin
- EBITDA₹4.66 Cr
FY 2024 · 24% margin
- Employee Count46
Associated legal entities of Rivarp Medical
Rivarp Medical operates through Rivarp Medical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rivarp Medical Private Limited CIN U33110KA2015PTC081433 | Active | 07 Jul 2015 | Bangalore, Karnataka | ₹19.1 Cr | 46 | 4 | View details |
Products & Services of Rivarp Medical
Rivarp Medical offers a comprehensive portfolio of products and services, including Occlunix® Occluders, PTCA Balloon Catheters, and Kentrospine Implants.
Devices for closing heart defects like ASD and VSD.
Catheters for balloon dilatation in heart procedures.
Implants for spinal surgeries including cages and plates.
Apps and channels of Rivarp Medical
its YouTube channel Rivarp Medical has 12 subscribers and 4 videos.
Videos from Rivarp Medical
The most watched videos on Rivarp Medical's YouTube channel, Rivarp Medical (12 subscribers). Click a video to play it here.
More on Rivarp Medical.
Funding Insights of Rivarp Medical
- Total Rounds 1
All 1 funding rounds of Rivarp Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2026 | Seed | – | Futura Surgicare | – |
Board of directors of Rivarp Medical Private Limited (Rivarp Medical)
Rivarp Medical Private Limited is the primary company behind Rivarp Medical. The board of Rivarp Medical Private Limited currently have 4 directors; the longest-serving is Mavidipalli Thyagarajulu Naidu, appointed in 2017. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mavidipalli Thyagarajulu Naidu DIN 01955425 | Director | 23 Oct 2017 | 9 yrs | Rivarp Medical Private Limited |
| Mavidiapalli Karunakumari DIN 01957727 | Director | 22 Feb 2018 | 8 yrs 8 mo | Rivarp Medical Private Limited |
| Arcot Sreedhar Rajanish DIN 01955707 | Director | 08 Feb 2020 | 6 yrs 8 mo | Rivarp Medical Private Limited |
| Rajashekar Basanagowda Donthal DIN 08765338 | Director | 03 Jun 2020 | 6 yrs 5 mo | Rivarp Medical Private Limited |
Financials of Rivarp Medical
Figures of Rivarp Medical Private Limited, the primary company behind Rivarp Medical, for FY 2024. Revenue was ₹19.12 Cr (+32% year on year). Net profit was ₹1.75 Cr (9% margin). EBITDA was ₹4.66 Cr (24% margin). Revenue has grown at a compounded annual rate of +90% over three years and +144% over five years.
- ₹19.12 CrRevenue · FY 2024 · +32% YoY
- ₹1.75 CrNet profit · 9% margin
- ₹4.66 CrEBITDA · 24% margin
- ₹1 LakhPaid-up capital
- 46Employees (provident fund records)
- +90%Revenue CAGR, 3 years
- +144%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rivarp Medical Private Limited are on its company page.
Detailed financial statements for Rivarp Medical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Rivarp Medical
2 dated milestones of Rivarp Medical across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Rivarp Medical is founded.
- Funding First funding round.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rivarp Medical
Rivarp Medical was founded in 2016 and raised its 1st funding round 10 years after it was founded.
Rivarp Medical is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rivarp Medical has 46 employees.
The primary company behind Rivarp Medical, Rivarp Medical Private Limited, reported revenue of ₹19.12 Cr for FY 2024, up 32% year on year.
Rivarp Medical Pvt. Ltd. focuses on designing and producing advanced medical devices, including occluders and catheters for cardiology interventions, as well as implants for spine surgeries. The company operates from Bangalore, India, emphasizing innovative healthcare solutions through manufacturing and distribution. Their products support medical professionals in treating heart defects and spinal conditions, serving hospitals and clinics worldwide.
Rivarp Medical offers Occlunix® Occluders, PTCA Balloon Catheters, and Kentrospine Implants.
Rivarp Medical operates through Rivarp Medical Private Limited.
The legal entities of Rivarp Medical currently have 4 directors, including Rajashekar Basanagowda Donthal, Mavidipalli Thyagarajulu Naidu, Mavidiapalli Karunakumari and others.